Achyut Healthcare Ltd vs Bafna Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Achyut Healthcare Ltd is ₹ 6.5 as of 12 Jun 15:30 . The P/E Ratio of Achyut Healthcare Ltd changed from 342.5 on March 2022 to 163 on March 2025 . This represents a CAGR of -16.94% over 4 yearsThe P/E Ratio of Bafna Pharmaceuticals Ltd changed from 55.8 on March 2021 to 42.6 on March 2025 . This represents a CAGR of -5.26% over 5 years The Market Cap of Achyut Healthcare Ltd changed from ₹ 13.85 crore on March 2022 to ₹ 76.79 crore on March 2025 . This represents a CAGR of 53.45% over 4 yearsThe Market Cap of Bafna Pharmaceuticals Ltd changed from ₹ 324.8 crore on March 2021 to ₹ 177.42 crore on March 2025 . This represents a CAGR of -11.39% over 5 years The revenue of Achyut Healthcare Ltd for the Mar '26 is ₹ 4.53 crore as compare to the Dec '25 revenue of ₹ 1.61 crore. This represent the growth of 181.37% The revenue of Bafna Pharmaceuticals Ltd for the Mar '26 is ₹ 44 crore as compare to the Dec '25 revenue of ₹ 39.51 crore. This represent the growth of 11.36% The ebitda of Achyut Healthcare Ltd for the Mar '26 is ₹ 0.17 crore as compare to the Dec '25 ebitda of ₹ 0.04 crore. This represent the growth of 325% The ebitda of Bafna Pharmaceuticals Ltd for the Mar '26 is ₹ 5.31 crore as compare to the Dec '25 ebitda of ₹ 4.27 crore. This represent the growth of 24.36% The net profit of Achyut Healthcare Ltd changed from ₹ 0.03 crore to ₹ 0.06 crore over 6 quarters. This represents a CAGR of 58.74% The net profit of Bafna Pharmaceuticals Ltd changed from ₹ -0.72 crore to ₹ 2.75 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Achyut Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Bafna Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Achyut Healthcare Ltd

Achyut Healthcare Limited was incorporated as Achyut Securities Private Limited' on January 11, 1996 as a Private Limited Company under the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Haveli.
The Company name was changed to Achyut Healthcare Private Limited', and a fresh Certificate of Incorporation dated November 26, 2002.
Subsequently, the Company got converted from a Private Limited to Public Limited and the name of the Company changed to Achyut Healthcare Limited', and a fresh Certificate of Incorporation dated November 30, 2021 was issued to the Company by Registrar of Companies, Gujarat at Ahmedabad. The Company is engaged in trading of Cenzure, Arpimune, Azathioprine IP, Everolimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phthalate, Chlorthalidone IP, Croscarmellose Sodium IP/USP, DIBasic Calcium Phosphate IP, DIEthyl Phthalate, Diltiazem Hydrochloride IP, Easy Coat Fc Titanium Dioxide, Escitalopram IP, Escitalopram Oxalate, Favipiravir among many other products.

About Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and is engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non Betalactum products.
The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a.
Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990. Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern.
During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products.

FAQs for the comparison of Achyut Healthcare Ltd and Bafna Pharmaceuticals Ltd

Which company has a larger market capitalization, Achyut Healthcare Ltd or Bafna Pharmaceuticals Ltd?

Market cap of Achyut Healthcare Ltd is 156 Cr while Market cap of Bafna Pharmaceuticals Ltd is 393 Cr

What are the key factors driving the stock performance of Achyut Healthcare Ltd and Bafna Pharmaceuticals Ltd?

The stock performance of Achyut Healthcare Ltd and Bafna Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Achyut Healthcare Ltd and Bafna Pharmaceuticals Ltd?

As of June 14, 2026, the Achyut Healthcare Ltd stock price is INR ₹6.5. On the other hand, Bafna Pharmaceuticals Ltd stock price is INR ₹166.25.

How do dividend payouts of Achyut Healthcare Ltd and Bafna Pharmaceuticals Ltd compare?

To compare the dividend payouts of Achyut Healthcare Ltd and Bafna Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.